Skip Header

 
Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot O95236 (APOL3_HUMAN)

Last modified November 24, 2009. Version 77. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Apolipoprotein L3
Alternative name(s):
    Apolipoprotein L-III
      Short name=ApoL-III
    TNF-inducible protein CG12-1
      Short name=CG12_1
Gene names
Name: APOL3
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length402 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at transcript level.

General annotation (Comments)

Function

May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles.

Subcellular location

Cytoplasm Probable.

Tissue specificity

Widely expressed; the highest levels are in prostate, lung and placenta; also detected in kidney, bone marrow, spleen, thymus, spinal cord, adrenal gland, salivary gland, trachea and mammary gland; levels are low in brain, heart, fetal liver, pancreas and testis.

Induction

In vitro, is responsive to tumor necrosis factor.

Sequence similarities

Belongs to the apolipoprotein L family.

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: O95236-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: O95236-2)

The sequence of this isoform differs from the canonical sequence as follows:
     1-74: MGLGQGWGWE...CSHSFKRSFL → MDS
Isoform 3 (identifier: O95236-3)

The sequence of this isoform differs from the canonical sequence as follows:
     1-200: Missing.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 402402Apolipoprotein L3
PRO_0000137602

Natural variations

Alternative sequence1 – 200200Missing in isoform 3.
VSP_000294
Alternative sequence1 – 7474MGLGQ…KRSFL → MDS in isoform 2.
VSP_000293
Natural variant391S → R: dbSNP rs132653. Ref.2
VAR_053007
Natural variant1351A → V: dbSNP rs6000152.
VAR_047488

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified November 25, 2008. Version 3.
Checksum: 8356C8247817F66A

FASTA40244,278
        10         20         30         40         50         60 
MGLGQGWGWE ASCFACLIRS CCQVVTFTFP FGFQGISQSL ENVSGYYADA RLEVGSTQLR 

        70         80         90        100        110        120 
TAGSCSHSFK RSFLEKKRFT EEATKYFRER VSPVHLQILL TNNEAWKRFV TAAELPRDEA 

       130        140        150        160        170        180 
DALYEALKKL RTYAAIEDEY VQQKDEQFRE WFLKEFPQVK RKIQESIEKL RALANGIEEV 

       190        200        210        220        230        240 
HRGCTISNVV SSSTGAASGI MSLAGLVLAP FTAGTSLALT AAGVGLGAAS AVTGITTSIV 

       250        260        270        280        290        300 
EHSYTSSAEA EASRLTATSI DRLKVFKEVM RDITPNLLSL LNNYYEATQT IGSEIRAIRQ 

       310        320        330        340        350        360 
ARARARLPVT TWRISAGSGG QAERTIAGTT RAVSRGARIL SATTSGIFLA LDVVNLVYES 

       370        380        390        400 
KHLHEGAKSA SAEELRRQAQ ELEENLMELT QIYQRLNPCH TH 

« Hide

Isoform 2.

Checksum: C7703BAE5D0302FA
Show »

FASTA33136,545
Isoform 3.

Checksum: 3C560B4F74CE837E
Show »

FASTA20221,597

References

« Hide 'large scale' references
[1]"Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes."
Horrevoets A.J.G., Fontijn R.D., van Zonneveld A.J., de Vries C.J.M., ten Cate J.W., Pannekoek H.
Blood 93:3418-3431(1999) [PubMed: 10233894] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
Tissue: Endothelial cell.
[2]"Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene."
Duchateau P.N., Pullinger C.R., Cho M.H., Eng C., Kane J.P.
J. Lipid Res. 42:620-630(2001) [PubMed: 11290834] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2 AND 3), VARIANT ARG-39.
Tissue: Pancreas.
[3]"The human apolipoprotein L gene cluster: identification, classification, and sites of distribution."
Page N.M., Butlin D.J., Lomthaisong K., Lowry P.J.
Genomics 74:71-78(2001) [PubMed: 11374903] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
Tissue: Placenta.
[4]"A genome annotation-driven approach to cloning the human ORFeome."
Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A., Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J., Beare D.M., Dunham I.
Genome Biol. 5:R84.1-R84.11(2004) [PubMed: 15461802] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
[5]"The DNA sequence of human chromosome 22."
Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M. expand/collapse author list , Buck D., Burgess J., Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A., Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C., Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L., Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L., Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N., Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R., Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y., Wright H.
Nature 402:489-495(1999) [PubMed: 10591208] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[6]Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. expand/collapse author list , Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C.
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[7]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
Tissue: Blood and Testis.
+Additional computationally mapped references.

Cross-references

Sequence databases

AF070675 mRNA. Translation: AAC83233.1.
AF324238, AF324233, AF324237 Genomic DNA. Translation: AAK26528.1.
AY014904 mRNA. Translation: AAG50346.1.
AF324238, AF324236, AF324237 Genomic DNA. Translation: AAK26529.1.
AY014902 mRNA. Translation: AAG50344.1.
AY014903 mRNA. Translation: AAG50345.1.
AY014905 mRNA. Translation: AAG50347.1.
AF324238 Genomic DNA. Translation: AAK26527.1.
AY014906 mRNA. Translation: AAG50348.1.
AY014907 mRNA. Translation: AAG50349.1.
AF305227 mRNA. Translation: AAK20213.1.
CR456379 mRNA. Translation: CAG30265.1.
Z95114 Genomic DNA. Translation: CAQ08518.1.
Z95114 Genomic DNA. Translation: CAQ08519.1.
CH471095 Genomic DNA. Translation: EAW60080.1.
BC042918 mRNA. Translation: AAH42918.1.
BC050596 mRNA. Translation: AAH50596.1.
IPIIPI00157607.
IPI00302796.
IPI00335164.
RefSeqNP_663615.1.
NP_663616.1.
NP_663617.1.
UniGeneHs.474737

3D structure databases

ModBaseSearch...

Protein-protein interaction databases

STRINGO95236.

Proteomic databases

PRIDEO95236.

Genome annotation databases

EnsemblENST00000349314; ENSP00000344577; ENSG00000128284; Homo sapiens. [Genome view]
GeneID80833.
KEGGhsa:80833.
UCSCuc003aoq.1. human.

Organism-specific databases

CTD80833.
GeneCardsGC22M034860.
HGNCHGNC:14868. APOL3.
MIM607253. gene.
PharmGKBPA24906.
GenAtlasSearch...

Phylogenomic databases

HOGENOMO95236.
HOVERGENO95236.
OMATIGSEIR

Gene expression databases

ArrayExpressO95236.
BgeeO95236.
CleanExHS_APOL3.
GenevestigatorO95236.
GermOnlineENSG00000128284. Homo sapiens.

Family and domain databases

InterProIPR008405. ApoL.
[Graphical view]
PANTHERPTHR14096. ApoL. 1 hit.
PfamPF05461. ApoL. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio71256.
SOURCESearch...

Entry information

Entry nameAPOL3_HUMAN
AccessionPrimary (citable) accession number: O95236
Secondary accession number(s): B1AHI4 expand/collapse secondary AC list , B1AHI5, Q5U5N4, Q9BQ82, Q9BQA3
Entry history
Integrated into UniProtKB/Swiss-Prot: May 30, 2000
Last sequence update: November 25, 2008
Last modified: November 24, 2009
This is version 77 of the entry and version 3 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 22

Human chromosome 22: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents